Can AMD develop in one eye first or usually both? 

Age related macular degeneration is a condition that frequently manifests in a complex and asymmetrical manner. While it is naturally a systemic ageing process that affects the retinal tissues, it does not always progress at the same rate in each eye. Many individuals in the United Kingdom find that their symptoms begin in just one eye, while others may be diagnosed with the condition in both eyes simultaneously during a routine screening. Because the human brain is highly adept at compensating for visual deficiencies, it is entirely possible for a person to have significant macular damage in one eye without being aware of it, as the “good” eye fills in the gaps in their central field of vision. 

What We’ll Discuss in This Article 

• The distinction between unilateral and bilateral presentation of AMD. 

• Why the brain can often mask vision loss when only one eye is affected. 

• Statistical probabilities of the second eye becoming involved over time. 

• The phenomenon of asymmetrical AMD, where each eye has a different stage or type. 

• How UK clinical protocols manage and monitor the “better seeing” eye. 

• Practical methods for checking your vision individually to catch early changes. 

The frequency of unilateral versus bilateral onset 

When age related macular degeneration first develops, it can appear in either one eye (unilateral) or both eyes (bilateral). Clinical data suggests that while the underlying biological changes, such as the buildup of drusen, often occur in both eyes eventually, the symptoms usually start asymmetrically. Approximately 65% of people diagnosed with AMD are found to have the same stage of the disease in both eyes at the time of their initial assessment. However, the remaining 35% may have significant differences in how each eye is functioning. 

In many cases, the dry form of the condition is what starts asymmetrically. A person may have several large drusen in one eye while the other appears relatively clear. Over time, as the metabolic waste continues to accumulate, the second eye typically catches up. Because the progression can be so varied, it is common for one eye to maintain excellent vision for several years while the other begins to struggle with tasks like reading or seeing fine detail. This asymmetrical start is why a comprehensive eye exam involves testing each eye individually rather than just assessing how a person sees with both eyes open. 

The brain’s compensation and the “hidden” vision loss 

One of the most remarkable aspects of how we see is the brain’s ability to create a single, clear image from two separate visual inputs. This process, known as binocular fusion, can inadvertently hide the symptoms of macular degeneration if it is only present in one eye. If the right eye begins to develop a blurred spot or a dark patch in its central vision, the left eye if healthy will provide the brain with the missing information. The brain then “stitches” these images together, often leaving the individual completely unaware that one eye is failing. 

This compensation effect is the primary reason why many people in the UK are surprised to learn they have advanced AMD during a routine check-up. It is often only when the individual happens to close or cover their “good” eye perhaps while rubbing it or during a simple vision test that they realise the vision in the other eye is distorted or missing. This highlights the critical importance of regular, individual eye monitoring. You can learn more about how vision is affected in one or both eyes through the specific patient guides provided by NHS 111 Wales. 

Probability of the second eye becoming involved 

Once age related macular degeneration is confirmed in one eye, the likelihood of the second eye being affected increases significantly over time. For those diagnosed with the early or intermediate dry form of the disease in one eye, studies have shown that the second eye is affected within five years in roughly 19% to 28% of cases. The progression is not guaranteed, but it is a strong clinical possibility that requires ongoing vigilance from both the patient and their eye care professional. 

The risk is notably higher for those who develop the wet form of AMD in one eye. Data from UK clinical audits suggests that approximately 50% of patients who have wet AMD in one eye will also develop the same condition in their second eye within five years. The risk is estimated at about 12% after the first year and rises to around 27% by the fourth year. Because wet AMD can cause such rapid sight loss, these statistics drive the urgency of follow up appointments in the UK healthcare system. A detailed annual report from the National Ophthalmology Database Audit highlights how these progression rates are monitored to improve patient outcomes across the country. 

Asymmetrical AMD: Mixed types and stages 

It is a common misconception that a person must have the same type of AMD in both eyes. It is possible to have “mixed” or asymmetrical AMD. For instance, an individual might have the slow-moving dry form in their right eye while simultaneously developing the more aggressive wet form in their left eye. Alternatively, one eye might have advanced geographic atrophy (late-stage dry AMD) while the other eye only shows early stage drusen. 

This asymmetrical nature requires a highly tailored approach to treatment. While the wet eye may require regular anti VEGF injections to stop blood vessel leakage, the dry eye might only require monitoring and the use of magnifying aids. This “split” diagnosis can be confusing for patients, but it underscores the fact that each eye is an independent biological unit that can respond differently to the ageing process. UK specialists often focus heavily on protecting the vision in the “better seeing” eye, as this is the eye that will sustain the person’s independence if the other eye’s vision continues to decline. 

Comparison of One-Eye vs. Both-Eye Involvement 

Feature	Unilateral AMD (One Eye)	Bilateral AMD (Both Eyes)
Detection	Often missed; “good” eye compensates	Usually noticed during daily tasks
Driving	May still meet DVLA standards	High risk of falling below standards
Risk of Progression	High risk (approx. 25-50% in 5 years)	Focus shifts to managing advanced stages
Impact on Depth Perception	Can be significantly affected	Generally, less impact if vision is equal
UK Monitoring	Frequent checks of the “good” eye	Monitoring both for treatment efficacy

The importance of the “good” eye in clinical management 

In the UK, the clinical management of macular degeneration is often driven by the status of the “better seeing” eye. If a patient has already lost significant central vision in one eye, preserving the sight in the remaining eye becomes the absolute priority. This is because having at least one eye with good central vision allows a person to continue reading, driving, and living independently. 

When the first eye is affected by wet AMD, the monitoring for the second eye becomes much more intensive. Patients are often given an Amsler grid and instructed to check the second eye every single day. The goal is to catch any transition to wet AMD in the second eye at the earliest possible moment, ideally before the patient even notices a change in their binocular vision. Because the results of treatments like eye injections are much better when the vision is still relatively good, this proactive approach is the cornerstone of UK ophthalmic care. Further technical details on these referral and treatment pathways can be found in the clinical guidance from University Hospitals Coventry & Warwickshire. 

Conclusion 

Age related macular degeneration can develop in one eye first or both eyes at the same time, though it often begins asymmetrically. The risk of the second eye becoming involved is high, particularly with the wet form of the condition, where there is a 50% chance of bilateral involvement within five years. Because the brain often masks the symptoms when only one eye is affected, regular individual eye testing is the most effective way to detect early changes and protect long term sight. If you experience severe, sudden, or worsening symptoms, call 999 immediately. 

Authority Snapshot 

This article explores the presentation of AMD in one or both eyes, focusing on UK patient education. It has been written by the Medical Content Team and reviewed by Dr. Rebecca Fernandez, a physician with extensive experience in internal medicine and emergency care. The content follows the clinical frameworks of the NHS and NICE to ensure that patients receive accurate, conservative, and useful guidance regarding their eye health and progression risks.